deutsche investment trust

att: john millette vp & sec.
one beacon street, 11th floor
boston, massachusetts 02108

NYS Entity Status

Registered Agent
NONE

NYS Entity Type
GENERAL ASSOCIATION LAW FILING

Name History
2014 - DEUTSCHE INVESTMENT TRUST









Buffer



submit to reddit

Telephone
n/a

Fax
n/a

Website
n/a

Email address
n/a

LinkedIn
n/a

Facebook
n/a

Google+
n/a

Twitter
n/a

Pinterest
n/a

Instagram
n/a



  • AROUND THE WEB

  • Bill Gates Backs Fourth Metamaterials Spinout, Pivotal Commware
    By Benjamin Romano - Friday Jun 16, 2017

    Pivotal Commware, a year-old metamaterials startup built inside patent licensing and invention business Intellectual Ventures, has raised $17 million from investors including Bill Gates. If that sounds familiar, it should. Pivotal is the fourth Gates-backed company to spin out of Intellectual Ventures armed with software-driven radio-wave bending metamaterials technology. Like its sister companies in satellite […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Boston Foundation Pledges $10 Million for Workforce Development
    By webmaster@philanthropynewsdigest.org (Matt Sinclair) - Thursday Jun 22, 2017

    The investment is expected to help create three thousand jobs in the greater Boston region....

    Source: Philanthropy News Digest (PND)
  • REITs for Good: Nonprofit Turns High-dollar Investment Tool Upside-down
    By Kevin Johnson - Tuesday Jun 6, 2017

    Real estate trust investments are most often held by pension funds or the biggest investors, but an anti-poverty group has created its own version.

    Source: Nonprofit Quarterly
  • The Small Business Report, January 3, 2017
    By info@compassmedianetworks.com (Compass Media Networks) - Tuesday Jan 3, 2017

    Businesses to launch in 2017; and how small, rural colleges are trying to save themselves by pumping investments into their small towns.

    Source: The Wall Street Journal: Wall Street Journal on Small Business
  • Checkmate Pharma Clinches $27M for More Studies in Skin Cancer
    By Frank Vinluan - Thursday Jun 15, 2017

    Checkmate Pharmaceuticals believes its approach to cancer treatment can make a certain type of immunotherapy work better, and it now has $27 million in additional funding to help build that case. F-Prime Capital Partners, a new investor, led the Series B round of investment announced Thursday. Sofinnova Partners and venBio, who had invested in Cambridge, […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Harvard Biotech Spinout Lands $10M to Make Platelets From Stem Cells
    By Frank Vinluan - Thursday Jun 8, 2017

    If you’ve donated blood, you probably received a follow-up message asking you to consider a platelet donation. Donation centers must constantly replenish their blood supplies, but the need for platelets is particularly acute. Compared to other components of blood, platelets are fragile and short lived, which puts high demand on the small supply of these […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Rubius Adds $120M to Ready Tests of Red Blood Cells as Drug Carriers
    By Frank Vinluan - Wednesday Jun 21, 2017

    The main role of red blood cells is to carry life-sustaining oxygen throughout the body. Rubius Therapeutics believes these cells can carry something more: therapeutic payloads delivered directly to the organs and tissues of patients with severe diseases. Less than two years after launch, Cambridge, MA-based Rubius has reeled in $120 million in funding from […]

    Source: Xconomy VC, Deals, & Startups Feed
  • Ascendant Network, Signal Study Confirms Customer Focus Pays Off
    Wednesday Jun 14, 2017

    Consumers favor brands that are willing to invest in the technology to deliver connected and personal customer experiences. Many of them invest in tech to keep data safe. About 62% of consumers said they favor certain travel and hospitality brands because they trust them with their data.

    Source: Media Post: Email Marketing Daily